U.S.-based telehealth firm Hims & Hers is preparing to launch replica versions of popular obesity medications in the UK and Europe, signaling an aggressive expansion into the global weight-loss market. The company says the move is part of a broader strategy to offer more affordable and accessible treatment options through its digital healthcare platform.